Welcome to our dedicated page for Trueblue SEC filings (Ticker: TBI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sorting through TrueBlue’s multi-segment disclosures can feel overwhelming—variable payroll liabilities, insurance reserves and Affinix technology spend are buried in hundreds of pages. Investors often ask, “Where do I find TrueBlue insider trading Form 4 transactions?” or “How is seasonal demand reflected in the latest TrueBlue quarterly earnings report 10-Q filing?”
Stock Titan solves that problem with AI-powered summaries that turn dense language into plain English. The moment a 10-K, 10-Q, 8-K or proxy hits EDGAR, our engine extracts the numbers that matter—gross margin by segment, cash-flow swings tied to weekly payroll, and executive incentive targets—so you can understand TrueBlue SEC filings explained simply without scrolling line-by-line.
- Real-time alerts for TrueBlue Form 4 insider transactions—know when leaders buy or sell shares.
- One-click access to every TrueBlue annual report 10-K simplified for trend analysis.
- Contextual highlights of TrueBlue proxy statement executive compensation and incentive metrics.
- Instant parsing of TrueBlue 8-K material events explained, from acquisitions to segment restructuring.
Need deeper insight? Our platform pairs machine learning with human expertise to deliver TrueBlue earnings report filing analysis that surfaces segment-level revenue shifts and worker-comp cost trends. Whether you are monitoring TrueBlue executive stock transactions Form 4 in real time or simply understanding TrueBlue SEC documents with AI, Stock Titan gives you comprehensive coverage—every filing type, every footnote, always current.
Insider sale by TrueBlue CEO/President and Director. The filing shows that Taryn R. Owen, who serves as CEO and President and a director, reported a sale of 1,436 shares of TrueBlue, Inc. (TBI) on
The Form 4 was signed by an attorney-in-fact on
TrueBlue, Inc. (TBI) insider sale by CEO — The CEO and President, Owen Taryn R, reported a sale of 2,472 shares of common stock on
TrueBlue, Inc. insider Jason Embick, Senior Vice President and Chief Accounting Officer, reported a sale of 700 shares of Common Stock on 09/03/2025 at a price of $5.72 per share. After the sale he beneficially owns 33,648 shares directly. The Form 4 was signed by an attorney-in-fact on 09/05/2025.
Royce & Associates LP filed Amendment No. 3 to Schedule 13G reporting its ownership in TrueBlue, Inc. (TBI) as of 30 Jun 2025.
- Beneficial ownership: 2,360,082 common shares
- Ownership percentage: 7.90 % of outstanding shares
- Sole voting power: 2,360,082 shares; no shared voting power
- Sole dispositive power: 2,360,082 shares; no shared dispositive power
The filer is classified as an investment adviser (Rule 13d-1(b)(1)(ii)(E)) and certifies the shares were acquired in the ordinary course of business, without intent to influence control of the issuer. Royce & Associates, an indirect majority-owned subsidiary of Franklin Resources, disclaims group status with other Franklin affiliates and any pecuniary interest beyond its clients’ accounts.
FAQ
What is the current stock price of Trueblue (TBI)?
What is the market cap of Trueblue (TBI)?
